Australia
Korean PE consortium named preferred bidder for Arrium
A consortium headed by two Korean private equity firms and supported by domestic steelmaker Posco has been selected as the preferred bidder for distressed Australian mining and minerals giant Arrium.
Sapphire leads Series C for Australia's Culture Amp
Sapphire Ventures has led a $20 million Series C funding round for Australian business analytics services provider Culture Amp.
PE-owned Blue Star Sports enters Australia, New Zealand
Blue Star Sports, a US-based company controlled by Genstar Capital that provides management software to grassroots sports clubs, has entered the Australia and New Zealand market with the acquisition of SportsTG.
Australia's Rokt closes Series B at $26m
Australian digital marketing services company Rokt has closed a Series B funding round at $26 million led by Moelis Australia Asset Management.
Carlyle, PEP to pay $930m for Australian pharma player
The Carlyle Group and Pacific Equity Partners (PEP) have finalized an agreement to jointly acquire Australia-based iNova Pharmaceuticals for $930 million in cash.
Blackbird joins $12m round for Australia-US marketing player
Blackbird Ventures has led a $12 million round for Sydney and San Francisco-based marketing software provider Autopilot.
Deal focus: IP Group targets tech commercialization
IP Group has built a business in the UK and US working with universities to turn academic ideas into investable business models. It has now raised $149 million for expansion in Australia and New Zealand
KKR bids $1.6b for Australian telecom player Vocus
KKR has offered to acquire Vocus Group, one of Australia's leading high-speed broadband internet providers, in a deal worth approximately A$2.1 billion ($1.6 billion).
Australian VCs invest $16m in domestic drug developer
Australian VC investors Brandon Capital and Uniseed have committed $16 million to Que Oncology, a clinical-stage drug development company established by the University of Queensland (UQ) and US-based Emory University.
OneVentures invests $7.4m in Australia’s Prota Therapeutics
Australia’s OneVentures has invested A$10 million ($7.4 million) in Prota Therapeutics, a domestic immunotherapy technology developer aiming to commercialize new peanut allergy treatments for children.
PE-owned Australian childcare providers to merge
Camp Australia, an outside school hours care provider acquired by Bain Capital Private Equity in February, has agreed to merge with Junior Adventures Group (JAG), a similar business controlled by Advent Partners.
Deal focus: Quadrant cashes in on Icon’s growth potential
Quadrant Private Equity agrees a $746 million exit from Icon Group, with new owners QIC, Goldman Sachs and Pagoda Investment keen to continue the cancer specialist's expansion in Asia
Temasek, Telstra back $149m Australian innovation push
IP Group, which specializes in commercializing intellectual property, has raised a new round of funding from investors including Temasek Holdings and Telstra Super, and pledged to invest A$200 million ($149 million) in Australia and New Zealand.
Australia VC: Meet the neighbors
Australia’s growing technology sector is set to benefit from long-term socioeconomic trends in Asia. Success will depend on both operational tenacity and a fundamental shift in expansion philosophy
Australia's Saluda Medical secures $40m round
Action Potential Venture Capital (APVC), an investment arm of British pharmaceutical company GlaxoSmithKline, has led a A$53 million ($40 million) all-equity Series D round for Australia’s Saluda Medical.
Australian adtech start-up Unlockd secures $23m
Malaysian telecommunications conglomerate Axiata has led a $23 million investment in early-stage Australian advertising technology company Unlockd.
Navis to sell Australia’s Retail Apparel to The Foschini Group
Navis Capital Partners has agreed to sell its controlling stake in Australia’s Retail Apparel Group (RAG) to The Foschini Group of South Africa in a deal worth A$302.5 million ($225 million).
Artesian closes $19.5m Australian cleantech fund
Australian venture capital firm Artesian Venture Partners has raised A$26 million ($19.5 million) for a domestic clean energy fund with a A$10 million cornerstone investment from the government’s A$1 billion Clean Energy Innovation Fund.
CITIC Capital in $600m Australian health acquisition
CITIC Capital China has joined a consortium including China’s Humanwell Healthcare to acquire the sexual health division of Australia-listed medical products supplier Ansell for $600 million.
Australia's CHAMP PE closes Fund IV at $547m
CHAMP Private Equity has reached a final close of A$735 million ($547 million) on its fourth Australia and New Zealand-focused fund.
Blue Sky exits Australia's HPS via $116m trade sale
Blue Sky Alternative Investors will exit its stake in HPS, Australia’s largest provider of outsourced pharmacy services to hospitals, as healthcare business EBOS agreed to buy the asset for A$154 million ($116 million).
Sino-Australian consortium to buy Icon Group from Quadrant
QIC, Goldman Sachs and Pagoda Investment – a China-focused private equity firm set up by a former QIC executive – have agreed to buy Icon Group, an Australian oncology services provider, from Quadrant Private Equity.
Hellman & Friedman submits $2.1b offer for Australia's Fairfax
Hellman & Friedman has submitted a buyout offer for Australia’s Fairfax Media that values the business as high as A$2.9 billion ($2.1 billion).
TPG, OTPP return with full buyout offer for Australia's Fairfax
TPG Capital and Ontario Teachers’ Pension Plan (OTTP) have revised their bid for Australia’s Fairfax Media to a full buyout that values the business at approximately A$2.75 billion ($2 billion).